Iede K, Yamada T, Takayama H, Nakashima S, et al. Poor Performance Status, Diabetes Mellitus, and Statin use are Risk Factors for Decreased Skeletal Muscle Mass During Nab-paclitaxel Plus Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer. Pancreas 2025 Sep 8. doi: 10.1097/MPA.0000000000002565.
PMID: 40911848